Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.

Mercer also said 64% of U.S. employers with over 20,000 employees covered weight-loss drugs in 2024, compared with 56% last ...

In 2024, the percentage of U.S. employers covering weight-loss drugs has increased, with notable rises among larger employers ...

This investor's weighing up a couple of world-class companies for his Stocks and Shares ISA after the US election sparked a sell-off.

Eli Lilly shares are down 11% since president-elect Donald Trump nominated Robert F. Kennedy, Jr. to be Secretary of Health ...

The move intensifies the competition with Eli Lilly, which secured approval for its weight loss drug in China in July but has ...

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It ...

Most of the top 20 are American. The first European company is in 25th place – Denmark’s Novo Nordisk, famed for its ...

Earlier in November, Novo Nordisk's Wegovy weight-loss drug sales beat its forecast, in an obesity drug market that some ...

European mega-caps trail US 'Magnificent 7' amid lack of AI gains, while also facing China’s slowdown and rising geopolitical ...

Catalent is vulnerable to facility closures whether from natural disasters or manufacturing issues, and a warning letter from the FDA or other regulatory agency can result in manufacturing delays or ...